Warp Drive Bio, Inc., a life sciences company developing therapeutics that exploit the molecules and mechanisms of nature, has reached a milestone in the antibiotic discovery program under its research collaboration with Sanofi. Sanofi will assume all preclinical and clinical development efforts for the novel aminoglycoside antibiotic candidates discovered by Warp Drive. This program is one of several natural product-based programs utilizing Warp Dive’s Genome Mining technology platform. “Ant...